Advertisement

Topics

InVivo Communications Company Profile

17:55 EDT 23rd June 2018 | BioPortfolio

Combining our expertise in communication, healthcare and financial markets, we enable our clients to communicate the true value to biotechnology investors

Biotech companies face communication challenges as their business is often perceived as high risk. The key for building trust and bridging the valuation gap between the biotech companies and the financial market is to effectively communicate the true values. In order to succeed, the values do not only need to be identified but also conveyed in an effective way.

InVivo Communications specializes in strategic financial communication for European biotechnology companies. Represented in Stockholm, London and Zürich, we communicate locally but on a global basis.

We offer deep experience and knowledge in communication, healthcare and financial markets. By combining these skills we work with our clients closely and on a long-term basis to identify, package and convey their investments stories to the financial and media community.



Location

Engelbrektsplan 2PO Box 3104
Stockholm
SE-103 62
Sweden

Contact

Phone: 46 8-679 49 50
Fax: 46 8-679 49 59
Email: info@invics.se


News Articles [177 Associated News Articles listed on BioPortfolio]

InVivo Therapeutics Chooses Richard Toselli for CEO Post

Richard Toselli has been named president and CEO of InVivo Therapeutics (NASDAQ: NVIV). Toselli had been acting CEO of the Cambridge, MA, medical device developer since December. Toselli will also con...

Active-Investors: Blog Exposure - InVivo Therapeutics Signs Share Repurchase Agreement with Lincoln Park Capital

LONDON, UK / ACCESSWIRE / January 29, 2018 / Active-Investors.com has just released a free research report on InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) ("InVivo Therapeutics"). If you want ...

FDA OKs second study of InVivo's neuro-spinal scaffold

The FDA has granted InVivo Therapeutics supplemental investigational device exemption approval to conduct a second pivotal st -More- 

InVivo Therapeutics announces pricing of $13.2M offering

A public stock offering has been priced by InVivo Therapeutics in hopes of raising $13.2 million in gross proceeds.  -More- 

Permanent CEO, president named by InVivo Therapeutics

Richard Toselli, who has been serving as acting CEO of InVivo Therapeutics since December, was appointed permanent CEO and pr -More- 

InVivo Therapeutics looks to raise $8M in offering

A registration has been filed by InVivo Therapeutics with the SEC for an offering of shares of common stock and Series A warr -More- 

InVivo announces reverse stock split, other company updates

A 1-for-25 reverse stock split was announced by InVivo Therapeutics, effective after market closing April 16 -- a move that w -More- 

InVivo Therapeutics, Lincoln Park reach $15M stock purchase deal

A stock purchase agreement has been reached by Lincoln Park Capital Fund to buy up to $15 million in shares from InVivo Thera -More- 

PubMed Articles [26 Associated PubMed Articles listed on BioPortfolio]

Communications of the median nerve in fetuses.

Communications between the median, ulnar and musculocutaneous nerves in the arm, forearm and hand were reported in adult cadaveric and electrophysiological studies. These communicant branches may lead...

Editorial: JCP Communications-Updating a valued community resource.

Simplified Submission Requirements for Authors of JACS Communications.

Public Health Issues in 2016 Presidential Campaign Communications.

Development and properties of duplex MgF2/PCL coatings on biodegradable magnesium alloy for biomedical applications.

The present work addresses the performance of polycaprolactone (PCL) coating on fluoride treated (MgF2) biodegradable ZK60 magnesium alloy (Mg) for biomedical application. MgF2 conversion layer was fi...

Clinical Trials [18 Associated Clinical Trials listed on BioPortfolio]

The Application of Invivo Microscopy Imaging in the Early Diagnosis of Cervical Cancer

This study intends to carry out a prospective, randomized controlled trial to research and development a new invivo microscopy based on the technology which is combined with high-definitio...

Multi-level Communications and Access Strategies to Improve the Food Environment

The overarching goal of B'More Healthy Retail Rewards (BHRR) is to develop, implement, and evaluate a pilot multi-level communications and pricing intervention to improve access to and con...

HERrespect Evaluation

This study evaluates whether a factory wide intervention, HERrespect, can reduce female garment workers' experiences of intimate partner violence, and experience and/or witnessing of viole...

Pilot Study In Vivo Confocal Microscopy Probe for Cervical Precancer

The goal of this proposal is to determine whether a hand-held confocal microscopy probe may perform better than standard methods in detecting cancer or pre-cancerous abnormalities of the c...

Improving the Outpatient Referral Process With Electronic Communications

An electronic referral application will be developed and integrated into the existing outpatient information system. The primary goal of this software is to improve the quality and coordi...

Companies [428 Associated Companies listed on BioPortfolio]

InViVo Communications Inc.

InViVo Communications Inc. is a leading healthcare new media company. Our boutique develops specialized communication programs and products for many biotechnology, global pharmaceutical and medical de...

Invivo

Invivo is the pioneer in innovative RF coils to increase image quality and improve diagnostic confidence. We are the world leader in MRI monitoring, providing accurate vital signs for improved patient...

InVivo Communications

Combining our expertise in communication, healthcare and financial markets, we enable our clients to communicate the true value to biotechnology investors Biotech companies face communication challeng...

InVivo Therapeutics Holdings Corp.

InVivo Therapeutics Holdings Corp. is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in in...

InVivo Therapeutics Corporation

InVivo Therapeutics Corporation is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in indiv...

More Information about "InVivo Communications" on BioPortfolio

We have published hundreds of InVivo Communications news stories on BioPortfolio along with dozens of InVivo Communications Clinical Trials and PubMed Articles about InVivo Communications for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of InVivo Communications Companies in our database. You can also find out about relevant InVivo Communications Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record